Panel Discussion: How ctDNA Testing is Informing the Management of Patients With GI Cancer
Our experts will review real-world case studies showing when and where ctDNA can help inform shared decision-making.
Watch Video
Our experts will review real-world case studies showing when and where ctDNA can help inform shared decision-making.
Watch Video
Listen in how one CRC patient and his physician used Signatera as a part of his treatment strategy to help identify an early signal that cancer may be lurking.
Watch Video
Watch Video
In this webinar, we explore how ctDNA can help bring clarity to common clinical scenarios including adjuvant treatment decision making, indeterminate findings and assessing treatment response.
Watch Video
Watch Video
Watch Video
Clinical Applications for Signatera in Breast Cancer Surveillance
Watch Video
Real World Case Study: Personalized ctDNA Testing for High Risk Breast Cancer Surveillance
Watch Video
Clinical utility of personalized ctDNA testing in breast cancer treatment
Watch Video
Clinical applications of ctDNA testing for MRD assessment in breast cancer
Watch Video
Watch Video
Webinar presents new ctDNA data from ASCOGU in muscle invasive bladder cancer and metastatic renal cell carcinoma
Watch Video
Clinical applications to support management of patients with high risk breast cancer
Watch Video
This webinar will explore the expanding role of circulating tumor DNA (ctDNA) for assessing molecular residual disease (MRD) and monitoring treatment response in patients with colorectal cancer.
Watch Video
Applications of personalized ctDNA testing to optimize treatment decisions in patients with GI cancers, presented by Dr. Adham Jurdi, MD
Watch Video
Watch Video
Watch Video
Watch Video
Watch Video
Watch Video
Loading More...